Soheila Aminimoghaddam - Department of Gynecology Oncology, Firoozgar Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran
Nima Azh - Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Somayyeh Noei Teymoordash - Department of Gynecology Oncology, Firoozgar Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran
Firouzeh Ghaffari - Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

Uterine cancer affects more than ۱.۲۸ million people worldwide; considering current world trends in obesity and aging, a +۵۲.۷% growth by ۲۰۴۰ is foreseen. Around ۵% of endometrial cancer patients are less than ۴۰ years old, meaning that conventional oncologic approaches would result in fertility loss; thus, it is essential to consult patients regarding their fertility and family planning. Owing to developments of oncofertility, patients are now able to preserve their fertility and complete their childbearing, drafting from the standard of care in endometrial cancer. Strict criteria should be applied to make sure of selecting patients who benefit most from the fertility preservation approach. Furthermore, careful selection of patients increases the possibility of successful treatment. Most candidates for fertility preservation have risk factors in common with infertility, including polycystic ovarian syndrome, obesity, increasing of age and irregular menses; therefore, Advanced Reproductive Technology (ART) can improve their chances for pregnancy. Current applied knowledge towards the fertility preservation approach in patients with endometrial cancer is reviewed in this article.

Endometrial Cancer, Fertility Preservation, Oncology, Gynecology, Oncofertility